EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Nanomedicine Tumor Targeting

Twan Lammers iD

Advanced Materials · 2024-06 · 36 (26)

DOI: 10.1002/adma.202312169 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 12.04.2024. Verfasst von Twan Lammers. Beteiligte Einrichtung: Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Center for Biohyhrid Medical Systems, University Hospital …. Hauptthemen laut MEDLINE: Neoplasms, Nanomedicine. Die Arbeit wurde bisher 310-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, German Research Foundation, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanomedicines are extensively explored for cancer therapy. By delivering drug molecules more efficiently to pathological sites and by attenuating their accumulation in healthy organs and tissues, nanomedicine formulations aim to improve the balance between drug efficacy and toxicity. More than 20 cancer nanomedicines are approved for clinical use, and hundreds of formulations are in (pre)clinical development. Over the years, several key pitfalls have been identified as bottlenecks in nanomedicine tumor targeting and translation. These go beyond materials‐ and production‐related issues, and particularly also encompass biological barriers and pathophysiological heterogeneity. In this manuscript, the author describes the most important principles, progress, and products in nanomedicine tumor targeting, delineates key current problems and challenges, and discusses the most promising future prospects to create clinical impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanomedicineHumansAnimalsAntineoplastic AgentsDrug Delivery SystemsNanoparticles

Stichwörter der Autor:innen

biomarkerscancerdrug deliverynanomedicinetumor targeting

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Center for Biohyhrid Medical Systems, University Hospital RWTH Aachen, Forckenbeckstrasse 55, 52074, Aachen, Germany.

ORCID-Profile: Twan Lammers

Förderung

  • European Research Council
  • German Research Foundation
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Lammers, T. (2024). Nanomedicine Tumor Targeting. Advanced Materials, 36(26). https://doi.org/10.1002/adma.202312169

Vancouver

Lammers T. Nanomedicine Tumor Targeting. Advanced Materials. 2024;36(26). doi:10.1002/adma.202312169

BibTeX
@article{Lammers2024,
  author = {Lammers, Twan},
  title = {Nanomedicine Tumor Targeting},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {26},
  doi = {10.1002/adma.202312169}
}
Kostenlos starten →